{
  "id": "6440092d57b1c7a315000040",
  "type": "yesno",
  "question": "Has RTA 408 received FDA approval?",
  "ideal_answer": "Yes, RTA 408 is FDA approved.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/33971103"
  ],
  "snippets": [
    {
      "text": "Forced overexpression of HO-1, pharmacological activation of HO-1 with the agonists RTA-408 (omaveloxolone, an FDA-approved drug) and RTA-402 repressed cell death, and treatment with HO-1 antagonist SnPP exacerbated the cell death. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/33971103",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "Yes"
}